As of July 2026, 3 paid clinical trials are recruiting for HER2-negative breast cancer in Washington D.C., District of Columbia. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Researchers run research studies in Washington D.C., DC at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| MedStar Washington Hospital Center | Breast Cancer, ARDS, ARDS (Acute Respiratory Distress Syndrome) | 95 |
| Children's National Medical Center | Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Neuroblastoma | 91 |
| Children's National Hospital | Sickle Cell Disease, Asthma in Children, Hypochondroplasia | 78 |
| MedStar Georgetown University Hospital | Malignant Solid Neoplasm, Breast Cancer, Acute Myeloid Leukemia | 78 |
| Sibley Memorial Hospital | Bladder Cancer, Breast Cancer, Brain Tumor | 43 |
| Georgetown University | Amyotrophic Lateral Sclerosis, HIV, Huntington's Disease | 35 |
| Georgetown University Medical Center | Breast Cancer, Locally Advanced Solid Tumor, Metastatic Solid Tumor | 33 |
| George Washington University Medical Center | Breast Cancer, Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma | 20 |
| George Washington University | HIV Infection, Advanced Solid Tumor, Advanced Solid Tumors | 18 |
| Children's National Health System | Anesthesia, Atopy, Autoimmunity | 12 |
| Georgetown Lombardi Comprehensive Cancer Center | Solid Tumor, Acute Myeloid Leukemia (AML) in Remission, Adenocarcinoma of Biliary Tract | 11 |
| Kaiser Permanente-Capitol Hill Medical Center | Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Breast Cancer | 10 |
| Washington Hospital Center | AIDS, Acute or Chronic Coronary Artery Disease, Aortic Valve Disease | 9 |
| MedStar Health Research Institute | Cancer, Cancer Pain, Central Line Associated Blood Stream Infections (CLABSI) | 9 |
| Childrens National Medical Center | Chronic Graft-versus-host-disease, Genetic Disease, Lymphatic Malformations | 7 |
| MedStar National Rehabilitation Hospital | Neurogenic Bladder, Multiple Sclerosis, Neurogenic Bladder (NB) | 7 |
| George Washington University Hospital | Abdominal Compartment Syndrome, Acute Kidney Injury, Atrial Fibrillation | 6 |
| MedStar Health | Acute DVT of Lower Extremity, Acute Limb Ischemia, Arterial Embolism and Thrombosis | 6 |
| Washington DC VA Medical Center, Washington, DC | Adult Growth Hormone Deficiency, Alcohol Use Disorder (AUD), BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | 6 |
| Childrens National Hospital | Chronic Graft-versus-host-disease, Ewing Sarcoma, Familial Hypercholesterolemia - Heterozygous | 5 |
| Clinical Trial Site | AQP4+ NMOSD, Atypical Hemolytic-Uremic Syndrome, Generalized Myasthenia Gravis | 5 |
| Children's National | Ablation, Becker Muscular Dystrophy, Cardiomyopathy | 4 |
| GSK Investigational Site | HIV Infections, Multiple Myeloma, Neoplasms, Head and Neck | 4 |
| George Washington University Medical Faculty Associates | Controlled Human Infection, Cutaneous Squamous Cell Carcinoma (CSCC), Focal Segmental Glomerulosclerosis | 4 |
| Georgetown University Hospital | Interstitial Lung Disease, Primary Immune Thrombocytopenia (ITP), Progressive Pulmonary Fibrosis | 4 |
Recruiting trials in Washington D.C. grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 833 recruiting clinical trials in Washington D.C., District of Columbia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Washington D.C. compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Washington D.C. include Breast Cancer (17), Sickle Cell Disease (12), Stroke (12), High Grade Glioma (9), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Washington D.C. on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Washington D.C. include MedStar Washington Hospital Center, Children's National Medical Center, Children's National Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Washington D.C. are Cancer & tumors (291), Neurology & pain (67), Cardiovascular (50). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.